Tuesday, March 04, 2025 | 09:51 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

News Digest: Top Newspaper Headlines

Image

Our Web Bureau Mumbai
 Business Standard

Sahara shares to go to a trust  

Sahara supremo Subrato Roy has decided to transfer the shares controlled by him in all his group companies to a trust in order to avoid any possibility of a family split.

Spentex pays Rs 128 crore for 49% in Indo Rama Textiles  

Deal valued at Rs 84.15 per share.

Growth is no sweet for India Inc 

Indian bosses' stress level growing slower than most.

The Economic Times 


Indorama SPL close to buying Nigeria's Eleme Petro for $225 mn

Deal is for 75% of equity capital of Nigerian company.

Sensex ends below 10K after 143-point slide

Profit-booking, pre-budget caution hits street.

Bahu wins Round I in Chhabria war


Court allows Vidya to divide Manu's assets among daughters, self.

The Hindu Business Line


Nimbus bags cricket rights for $612 mn

BCCI sale and sponsorship earnings total Rs 3,354 crore.

Rangarajan panel for reduction in customs duties on petrol, diesel


Also seeks freedom for oil companies to fix prices.

'Armed' with IIM course retirees march towards new careers


The highest salary for the outgoing batch stood at Rs 14 lakh per annum with average being between Rs 5 lakh and Rs 6 lakh a year .

The Financial Express


Anil to be non-retiring chariman of R-ADAG

Anil Ambani will become non-retiring chairman of the board of four of the demerged companies of Reliance Industries..

FM non-committal on states' demand

Finance ministry alleged that the compensation formula the states have proposed wasn't 'concret'..

Gucci steps in to India with Murjani

To open exclusive outlets in Mumbai and New Delhi by 2007.

Daily News & Analysis


Think 15%, President tells IT

A P J Abdul Kalam on Friday asked Indian infotech captains to stop aiming for 3.4% of the global IT/BPO market, our current market share, and instead gun for 15% of the pie, which would result in outsourcing deals worth $200 billion annually.

Ranbaxy exited as Betapharm 'became pricey'

Ranbaxy Laboratories said the company was an aggressive bidder for German generics major Betapharm Arzneimittel GmbH till the very last round. Then it pulled back, "because valuations were getting stretched".

Hexaware to set up unit in China 

Also on the cards is a campus in the east, possibly Kolkata or Bhuvaneshwar.

 
 

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 18 2006 | 10:01 AM IST

Explore News